Introduction
The 3-Hydroxy-3-Methylglutaryl Coenzyme A (HMG-CoA) reductase inhibitors
or statins are widely used in the primary and secondary prevention of
cardiovascular events (1).
Statins are usually well-tolerated and do not have many serious side
effects. One of the side effects that can affect the decision to
continue treatment with statins is musculoskeletal complications such as
tendinopathy, which is most common with Atorvastatin and Simvastatin
(2).
Statin-related musculoskeletal adverse effects (AE) vary from mild
myalgia and muscle weakness to tendinopathy and rhabdomyolysis (1). The
probable risk factors summarized in table 1.
Tendinopathy is usually presented with tendinitis and tendon rupture,
especially of the Achilles, quadriceps, and distal biceps tendons, which
mostly happen within the first year of initiation and improve after
discontinuation (3).
In this case report, we described a 58-years old man who experience
tendon rupture as an adverse effect of using statin.